Cholecystokinin expression in tumors: biogenetic and diagnostic implications

Research output: Contribution to journalReviewResearchpeer-review

Cholecystokinin (CCK) is a classic gut hormone. CCK is also a complex system of peptides expressed in several molecular forms in enteroendocrine I cells, in cerebral and peripheral neurons, in cardiac myocytes and spermatozoa. CCK gene expression has now been found at protein or peptide level in different neuroendocrine tumors; cerebral gliomas and astrocytomas and specific pediatric tumors. Tumor hypersecretion of CCK was recently reported in a patient with a metastatic islet cell tumor and hypercholecystokininemia resulting in a novel tumor syndrome, the cholecystokininoma syndrome. This review presents an overview of the cell-specific biogenesis of CCK peptides, and a description of the CCK expression in tumors and of the cholecystokininoma syndrome. Finally, assays for the diagnosis of CCK-producing tumors are reviewed.

Original languageEnglish
JournalFuture Oncology
Volume12
Issue number18
Pages (from-to)2135-47
Number of pages13
ISSN1479-6694
DOIs
Publication statusPublished - Sep 2016

    Research areas

  • Biomarkers, Tumor, Cell Proliferation, Cholecystokinin, Gene Expression Regulation, Neoplastic, Humans, Multigene Family, Neoplasms, Prognosis, Protein Binding, Protein Processing, Post-Translational, Protein Transport, RNA, Messenger, Receptors, Cholecystokinin, Journal Article, Review

ID: 176826933